Exercise bouts could improve efficacy of cancer drug

Press/Media: Research

Period21 May 2024

Media coverage

1

Media coverage

  • TitleExercise bouts could improve efficacy of cancer drug
    Country/TerritoryUK United Kingdom
    Date21/05/24
    DescriptionBouts of moderate-to-vigorous intensity exercise could improve the efficacy of antibody therapies used to treat chronic lymphocytic leukaemia, new research has shown.

    Researchers at the Universities of Birmingham and Bath found that a bout of exercise increased the number of anti-cancer immune cells – called natural killer cells – and that these cells were around twice as effective at killing cancer cells in ‘ex vivo’ tests carried out on blood samples from patients.

    In addition, the researchers found that the number of cancer cells present in blood samples transiently increased immediately after exercise – making them more susceptible to attack by natural killer cells and the antibody therapy.

    The research, funded by Cancer Research UK, could hold promise for antibody therapy treatment for some forms of cancer, although more work is needed to determine the ‘in vivo’ effects in patients undergoing treatment.

    Dr James Turner, a co-author on the study at the University of Birmingham, said: “These findings show a potential benefit to patients undergoing a very particular type of treatment and could open up new avenues of research to determine whether exercise can improve the way other cancer treatments work.”

    In the study, published in Brain Behaviour and Immunity, the researchers wanted to test the effects of exercise on an antibody therapy called Rituximab. It is a common treatment for chronic lymphocytic leukaemia, which is a cancer of white blood cells, and is the second most common adult blood cancer in the UK. The therapy works by attaching itself to a specific protein on the surface of cancer cells, which natural killer cells are able to recognise and attack.

    The researchers worked with 20 people between the ages of 45 and 82 who were diagnosed with chronic lymphocytic leukaemia but had not yet begun treatment. Participants were asked to do a 30 minute bout of moderate-to-vigorous intensity cycling. Blood samples were taken before and immediately after the exercise bout, and then a third sample was taken an hour later.

    In the blood samples, under ‘ex vivo’ conditions, the researchers measured the number of natural killer cells present at each of the sample points and tested their ability to kill cancer cells with and without Rituximab present.

    They found the number of natural killer cells increased by 254% after exercise and that in the blood samples taken after exercise, there were 67% more cancer cells compared to blood before exercise.

    Next, the team isolated natural killer cells and put them in close contact with cancer cells for 2 hours ‘ex vivo’ with and without the antibody therapy Rituximab. When Rituximab was also present in the blood sample, natural killer cells were just over twice as effective in killing the cancer cells in the samples collected immediately after exercise compared to before.

    Dr John Campbell, senior author of the study at the University of Bath said: “Cancer cells often try to ‘hide’ in the body but it seems that exercise works to move them out into the bloodstream, where they are vulnerable to the antibody therapy and the killing capabilities of natural killer cells”.

    The results of the study could also have potential for patients who have finished their treatment for leukaemia and are in a monitoring phase in case cancer cells re-appear.

    Dr Harrison Collier-Bain, first author of the study at the University Bath said: “Monitoring patients after treatment is complicated because if cancer cells remain or reappear, they are sometimes too low to detect, but a bout of exercise followed by a blood sample immediately afterwards could help to ‘find’ them if they are ‘hiding’ in the body”.

    While these results are promising, larger-scale trials would needed in a cohort of patients undergoing Rituximab treatment before treatment recommendations could be made.

    IN:

    Study shows bursts of exercise may boost antibody therapy for blood cancer
    Local 12, 10 Jun 2024

    Now 66 Tue 77 Wed 84 by Liz Bonis
    Medical News Today
    Short bouts of exercise may boost efficacy of some types of cancer…
    Medical News Today, 06 Jun 2024

    Share on PinterestCan exercise help boost cancer treatment for leukemia? Image credit: Jimena Roquero/Stocksy.
    LabRoots
    Moderate-Vigorous Exercise Boosts Antibody Therapy for Leukemia | Drug Discovery And Development
    LabRoots, 04 Jun 2024

    Moderate-vigorous intensity exercise could improve the efficacy of antibody therapies when treating leukemia.
    LabRoots
    Moderate-Vigorous Exercise Boosts Antibody Therapy for Leukemia | Drug Discovery And Development
    LabRoots, 04 Jun 2024

    Moderate-vigorous intensity exercise could improve the efficacy of antibody therapies when treating leukemia.
    LabRoots
    Moderate-Vigorous Exercise Boosts Antibody Therapy for Leukemia | Drug Discovery And Development
    LabRoots, 04 Jun 2024

    Moderate-vigorous intensity exercise could improve the efficacy of antibody therapies when treating leukemia.
    Medindia
    Breaking a Sweat: Exercise Boosts Rituximab Efficacy in Treating Leukemia
    Medindia, 25 May 2024

    New research indicates that bouts of moderate-to-vigorous intensity exercise could enhance the effectiveness of antibody…
    ecancer
    Exercise bouts could improve efficacy of cancer drug - ecancer
    ecancer, 22 May 2024

    Bouts of moderate-to-vigorous intensity exercise could improve the efficacy of antibody therapies used to treat chronic…
    The Medical News
    Exercise enhances efficacy of antibody therapy in leukemia patients
    The Medical News, 21 May 2024

    Bouts of moderate-to-vigorous intensity exercise could improve the efficacy of antibody therapies used to treat chronic…
    Health Medicinet
    Exercise bouts could improve efficacy of cancer drug
    Health Medicinet, 21 May 2024

    Representative gating strategy for CLL cells from one participant with treatment-naïve CLL.
    MSN
    Exercise bouts could improve efficacy of cancer drug
    MSN, 21 May 2024

    Bouts of moderate-to-vigorous intensity exercise could improve the efficacy of antibody therapies used to treat chronic…
    Nipponese.news
    運動は抗がん剤の効果を高める可能性がある - Nipponese
    Nipponese.news, 21 May 2024

    この記事は Science X に従ってレビューされています。 編集プロセス そして ポリシー。 編集者 コンテンツの信頼性を確保しながら、次の属性を強調しました。 事実確認済み 査読付き出版物 信頼できる情報源 校正する わかりました! 未治療の…
    MedicalXpress
    Exercise bouts could improve efficacy of cancer drug
    MedicalXpress, 21 May 2024

    Bouts of moderate-to-vigorous intensity exercise could improve the efficacy of antibody therapies used to treat chronic…
    Science Daily
    Exercise bouts could improve efficacy of cancer drug
    Science Daily, 21 May 2024

    Bouts of moderate-to-vigorous intensity exercise could improve the efficacy of antibody therapies used to treat chronic…
    EurekAlert!
    Exercise bouts could improve efficacy of cancer drug
    EurekAlert!, 21 May 2024

    Bouts of moderate-to-vigorous intensity exercise could improve the efficacy of antibody therapies used to treat chronic…
    ScienMag
    Exercise bouts could improve efficacy of cancer drug
    ScienMag, 21 May 2024

    Bouts of moderate-to-vigorous intensity exercise could improve the efficacy of antibody therapies used to treat chronic…
    Mirage News
    Workouts May Boost Cancer Drug Effectiveness
    Mirage News, 21 May 2024

    Bouts of moderate-to-vigorous intensity exercise could improve the efficacy of antibody therapies used to treat chronic…
    Bionewscentral
    Exercise bouts could improve efficacy of antibody therapy for chronic lymphocytic leukemia BioNews Central
    Bionewscentral, 21 May 2024
    Bouts of moderate-to-vigorous intensity exercise could improve the efficacy of antibody therapies used to treat chronic…


    PersonsJohn Campbell